US EditionSurGenTec® Achieves Key Milestone with Expanded Indications for OsteoFlo® HydroFiber™ – Ortho Spine News
BOCA RATON, Fla., July 22, 2025 – OrthoSpineNews – SurGenTec® has received additional FDA 510(k) clearance for OsteoFlo® HydroFiber, its advanced synthetic bone graft, marking another key regulatory milestone. This expansion of indications now includes use as a bone void filler for the treatment of tumors, cysts, trauma, and osteomyelitis. This landmark clearance represents a significant advancement in the capabilities of SurGenTec®’s cutting-edg
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
SurGenTec® Achieves Key Milestone with Expanded Indications for OsteoFlo® HydroFiber™ – Ortho Spine News
BOCA RATON, Fla., July 22, 2025 – OrthoSpineNews – SurGenTec® has received additional FDA 510(k) clearance for OsteoFlo® HydroFiber, its advanced synthetic bone graft, marking another key regulatory milestone. This expansion of indications now includes use as a bone void filler for the treatment of tumors, cysts, trauma, and osteomyelitis. This landmark clearance represents a significant advancement in the capabilities of SurGenTec®’s cutting-edg
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
